SE9902938D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
SE9902938D0
SE9902938D0 SE9902938A SE9902938A SE9902938D0 SE 9902938 D0 SE9902938 D0 SE 9902938D0 SE 9902938 A SE9902938 A SE 9902938A SE 9902938 A SE9902938 A SE 9902938A SE 9902938 D0 SE9902938 D0 SE 9902938D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical compositions
active ingredient
propylsulphonyl
nedocromil
phenylethoxy
Prior art date
Application number
SE9902938A
Other languages
Swedish (sv)
Inventor
John Dixon
Philip Holt
Francis Ince
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9902938A priority Critical patent/SE9902938D0/en
Publication of SE9902938D0 publication Critical patent/SE9902938D0/en
Priority to PCT/GB2000/003116 priority patent/WO2001012192A2/en
Priority to AU64603/00A priority patent/AU6460300A/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a pharmaceutical composition, pharmaceutical product or kit comprising a first active ingredient (A) being 4-hydroxy-7-[2-[2-[3-[2-phenylethoxy]propylsulphonyl]ethylamino]ethyl]-1,3-benzothiazol-2(3<i>H</i>)-one or a pharmaceutically acceptable salt thereof, and a second active ingredient (B) being disodium cromoglycate or nedocromil, for use in the treatment of obstructive airways diseases.
SE9902938A 1999-08-18 1999-08-18 Pharmaceutical compositions SE9902938D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9902938A SE9902938D0 (en) 1999-08-18 1999-08-18 Pharmaceutical compositions
PCT/GB2000/003116 WO2001012192A2 (en) 1999-08-18 2000-08-14 Pharmaceutical compositions comprising a-(2-aminoethyl)-benzothiazolone and disodium cromoglycate or nedocromil
AU64603/00A AU6460300A (en) 1999-08-18 2000-08-14 Pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9902938A SE9902938D0 (en) 1999-08-18 1999-08-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SE9902938D0 true SE9902938D0 (en) 1999-08-18

Family

ID=20416696

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9902938A SE9902938D0 (en) 1999-08-18 1999-08-18 Pharmaceutical compositions

Country Status (3)

Country Link
AU (1) AU6460300A (en)
SE (1) SE9902938D0 (en)
WO (1) WO2001012192A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE435855T1 (en) 2003-11-21 2009-07-15 Theravance Inc COMPOUNDS HAVING AGONISTIC ACTION ON THE BETA2-ADRENERGIC RECEPTOR AND THE MUSCARINIC RECEPTOR
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
AU2009260899B2 (en) 2008-06-18 2012-02-23 Astrazeneca Ab Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds

Also Published As

Publication number Publication date
AU6460300A (en) 2001-03-13
WO2001012192A3 (en) 2001-12-13
WO2001012192A2 (en) 2001-02-22

Similar Documents

Publication Publication Date Title
NO20034612L (en) 3,4-di-substituted cyclobutene-1,2-dione, pharmaceutical compositions comprising the compounds, and use of the compounds for the manufacture of medicaments for the treatment of chemokine-mediated diseases
WO2002085909A8 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
ATE504579T1 (en) ANTIVIRAL AGENTS
EA200301165A1 (en) Drug on the basis of oxycodone
CY2013041I1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
ATE248837T1 (en) QUINUCLIDINE-ACRYLAMIDE
CA2396561A1 (en) Substituted oxazolidinones and their use in the field of blood coagulation
GEP20053600B (en) 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
BR0210122A (en) Compound or a pharmaceutically acceptable salt thereof, method for treating or preventing a disease, use of the compound or salt thereof, and method for preparing the same
HK1072181A1 (en) Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
ITFI20030058A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING THIAZOLIDINEDIONI
SE9902935D0 (en) Pharmaceutical compositions
DE60035429D1 (en) USE OF SULFODE HYDROABETIC ACIDS FOR THE TREATMENT OF INFLAMMATORY ENDURANCE
SE9902937D0 (en) Pharmaceutical compositions
SE9902938D0 (en) Pharmaceutical compositions
HUP9802897A2 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
SE9902936D0 (en) Pharmaceutical compositions
HUP0402092A2 (en) Use of 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane and its physiologically acceptable salts for preparation of pharmaceutical compositions
BR0011845A (en) Pharmaceutical complex
HUP0402654A2 (en) 2-[(2&#39;-halo-3&#39;,5&#39;-dialkoxyphenyl)-imino]-imidazolidine derivatives, use thereof and pharmaceutical compositions containing them
DE60108354D1 (en) 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions
BR0213463A (en) Macrolide-containing pharmaceutical compositions
FR2843301B1 (en) GALENIC FORM FOR THE COLIC DELIVERY OF ACTIVE INGREDIENTS
WO2002036105A3 (en) Use of cortisol-sequestering agents for the treatment of hypercortisolaemia related disorders
NO20043889L (en) Pharmaceutical compositions comprising 2- (4-ethoxy-phenyl) -3- (4-methanesulfonyl-phenyl) -pyrazolo 1,5-bipyridazine in nanoparticle form